10x Genomics EPS beats by $0.17, beats on revenue; reaffirms outlook

May 05, 2021 4:06 PM ET10x Genomics, Inc. (TXG)TXGBy: Meghavi Singh, SA News Editor5 Comments
  • 10x Genomics (NASDAQ:TXG): Q1 GAAP EPS of -$0.11 beats by $0.17.
  • Revenue of $105.8M (+47.1% Y/Y) beats by $3.04M.

  • 2021 Financial Guidance: 10x Genomics is maintaining full year 2021 revenue guidance of $480 million to $500 million vs. consensus of $495.60M, representing 61% to 67% growth over full year 2020 revenue.

  • Press Release
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.